A detailed history of Rock Springs Capital Management LP transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 933,399 shares of AKRO stock, worth $26.5 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
933,399
Previous 1,074,261 13.11%
Holding current value
$26.5 Million
Previous $25.2 Million 6.26%
% of portfolio
0.91%
Previous 0.78%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$21.45 - $29.34 $3.02 Million - $4.13 Million
-140,862 Reduced 13.11%
933,399 $26.8 Million
Q2 2024

Aug 14, 2024

SELL
$18.31 - $24.62 $4.13 Million - $5.55 Million
-225,627 Reduced 17.36%
1,074,261 $25.2 Million
Q1 2024

May 15, 2024

BUY
$17.76 - $31.18 $3.89 Million - $6.82 Million
218,824 Added 20.24%
1,299,888 $32.8 Million
Q4 2023

Feb 14, 2024

SELL
$11.38 - $50.33 $3.85 Million - $17 Million
-338,086 Reduced 23.82%
1,081,064 $25.2 Million
Q3 2023

Nov 14, 2023

SELL
$41.19 - $52.25 $5.42 Million - $6.88 Million
-131,604 Reduced 8.49%
1,419,150 $71.8 Million
Q2 2023

Aug 14, 2023

BUY
$36.89 - $56.88 $3.56 Million - $5.49 Million
96,500 Added 6.64%
1,550,754 $72.4 Million
Q1 2023

May 15, 2023

BUY
$37.27 - $50.24 $2 Million - $2.69 Million
53,600 Added 3.83%
1,454,254 $55.6 Million
Q4 2022

Feb 14, 2023

BUY
$33.44 - $54.8 $1.03 Million - $1.68 Million
30,681 Added 2.24%
1,400,654 $76.8 Million
Q3 2022

Nov 14, 2022

BUY
$10.15 - $34.05 $7.01 Million - $23.5 Million
690,459 Added 101.61%
1,369,973 $46.6 Million
Q2 2022

Aug 15, 2022

BUY
$8.0 - $15.01 $354,400 - $664,943
44,300 Added 6.97%
679,514 $6.42 Million
Q1 2022

May 16, 2022

BUY
$12.97 - $22.26 $624,025 - $1.07 Million
48,113 Added 8.2%
635,214 $9.01 Million
Q4 2021

Feb 14, 2022

BUY
$19.87 - $26.24 $365,608 - $482,816
18,400 Added 3.24%
587,101 $12.4 Million
Q3 2021

Nov 15, 2021

BUY
$18.65 - $25.46 $747,865 - $1.02 Million
40,100 Added 7.59%
568,701 $12.7 Million
Q2 2021

Aug 16, 2021

BUY
$24.81 - $32.35 $184,338 - $240,360
7,430 Added 1.43%
528,601 $13.1 Million
Q1 2021

May 17, 2021

BUY
$24.04 - $34.19 $139,432 - $198,302
5,800 Added 1.13%
521,171 $15.1 Million
Q4 2020

Feb 16, 2021

BUY
$25.12 - $29.89 $2.32 Million - $2.76 Million
92,331 Added 21.83%
515,371 $13.3 Million
Q3 2020

Nov 16, 2020

BUY
$30.79 - $39.92 $5.54 Million - $7.19 Million
180,055 Added 74.1%
423,040 $13 Million
Q2 2020

Aug 14, 2020

BUY
$19.25 - $26.76 $346,211 - $481,278
17,985 Added 7.99%
242,985 $6.06 Million
Q2 2019

Aug 14, 2019

BUY
$18.08 - $19.83 $4.07 Million - $4.46 Million
225,000 New
225,000 $4.31 Million

Others Institutions Holding AKRO

About Akero Therapeutics, Inc.


  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $1.32B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.